Explore MarketSpeaker's latest reporting, research, and expert analysis tagged with "stock market", collected in one continuously updated archive.
Anthropic is reportedly in talks to raise up to $50 billion at a valuation approaching $900 billion, reflecting surging demand for AI investments.
Meta will begin paying creators in stablecoins through Stripe, starting in Colombia and the Philippines, as it expands digital payment options.
SpaceX’s planned dual-class share structure will give Elon Musk dominant voting power, allowing him to retain control over key decisions, including leadership changes.
SoftBank is preparing to spin off and list Roze, a new AI and robotics infrastructure company, in a potential $100 billion IPO in the U.S.
The UAE will exit OPEC and OPEC+ from May 1, aiming to increase oil production and better align with shifting global energy demand.
Finland’s Kone will acquire Germany’s TK Elevator in a $34.4 billion deal, forming the world’s largest elevator manufacturer.
UBS reported an 80% surge in first-quarter profit to $3 billion, beating expectations as trading revenue strengthened performance.
Elon Musk has begun testifying in his case against OpenAI, seeking to remove leadership and claim $134 billion in damages over alleged contract violations.
A wave of potential trillion-dollar IPOs from SpaceX, OpenAI, and Anthropic is fueling market excitement and raising concerns over investor positioning.
Microsoft will lose exclusive rights to OpenAI models, allowing broader distribution as the partnership evolves and revenue-sharing terms change.
A U.S. government investment in Intel has generated $25.7 billion in unrealized gains in just eight months after shares surged following earnings.
China has blocked Meta’s $2 billion acquisition of AI startup Manus, citing regulatory concerns over the cross-border deal.
SanDisk shares have surged 3000% over the past year as demand for AI data center storage fuels explosive growth.
Eli Lilly will acquire Ajax Therapeutics for up to $2.3 billion, strengthening its pipeline in blood cancer treatments.
Sun Pharma shares rose 7% after announcing an $11.75 billion deal to acquire U.S.-based Organon, expanding its global footprint.